NEXT

Jan Wolfe

Jan Wolfe

February 19, 2014 | Litigation Daily

Judge Won't Delay Final Approval of $8.5 Billion BofA Deal

A judge in Manhattan told AIG and other objectors to Bank of America's mortgage-backed securities mega-settlement to bring their beef with the deal to the U.S. Court of Appeals for the Second Circuit.

By Jan Wolfe

3 minute read

February 19, 2014 | Litigation Daily

S&C Knocks Out $500 Million Fraud Suit Against Philips

A 91-year-old Italian mogul's $500 million fraud case against Philips spanned seven years and implicated the laws of at least four nations. Now, thanks to Sullivan & Cromwell and a Delaware judge, the case may finally be kaput.

By Jan Wolfe

3 minute read

February 19, 2014 | The American Lawyer

Lawsuit Against State Farm Was A Good Investment

Litigation funder Bentham backed a roofing contractor battling the insurer for defamation—and made $2.2 million.

By Jan Wolfe

5 minute read

February 18, 2014 | Litigation Daily

Hotels, Travel Sites Beat Price-Fixing Class Action

A federal judge on Tuesday dismissed a class action lawsuit alleging that hotel chains and online travel companies conspired to fix the price of rooms booked online, handing a big win to a brigade of defense firms.

By Jan Wolfe

3 minute read

February 18, 2014 | Litigation Daily

Paul Weiss Strikes Out for Contorinis, Scores for Citi at Second Circuit

The firm couldn't reverse a ruling that a client convicted of insider trading must disgorge $7 million. But it did finish off a fraud case brought against longtime client Citigroup Inc. by a group of Norwegian investors represented by Kasowitz Benson Torres & Friedman.

By Jan Wolfe

3 minute read

February 18, 2014 | Litigation Daily

Boies, Bingham Clear Hurdle for Oracle in Rimini Street Suit

Boies, Schiller & Flexner and Bingham McCutchen scored a partial win in Oracle's copyright battle with Rimini Street, a smaller rival that offers low-cost support to Oracle customers.

By Jan Wolfe

3 minute read

February 14, 2014 | Litigation Daily

Keryx Biopharmaceuticals Fends Off Investor Suit

Keryx Biopharmaceuticals Inc. and its lawyers at Alston & Bird have defeated claims that the company misled investors about the results of a clinical trial for its cancer drug Perifosine.

By Jan Wolfe

2 minute read

February 14, 2014 | Litigation Daily

Indiana Court Finds IBM Botched $1.3 Billion State Contract

An appeals court ruled that IBM botched an assignment to privatize Indiana's welfare benefits system, putting the computing giant on the hook for as much as $177 million in damages. The decision is a major reversal of fortune for the state and its lawyers at Barnes & Thornburg, who were up against high-powered opponents at Kirkland & Ellis.

By Jan Wolfe

2 minute read

February 13, 2014 | Litigation Daily

Cadwalader Faces Narrowed Malpractice Claim Over Nomura Advice

With a long-awaited trial on the horizon, Cadwalader, Wickersham & Taft persuaded an appeals court to trim a $70 million malpractice suit brought by former client Nomura Asset Capital Corp., a sponsor of mortgage-backed securities.

By Jan Wolfe

3 minute read

February 13, 2014 | Litigation Daily

Litigator of the Week: U.S. Attorney Preet Bharara

Bharara has taken some flack for his choice of targets on Wall Street. But it's hard to argue with his record of insider trading convictions, which now stands at a stunning 79-0.

By Jan Wolfe

3 minute read